A Pilot Feasibility Study of 99mTc EC DG SPECT/CT Imaging in the Treatment Response Evaluation in Patients With Locally Advanced Head and Neck Cancer
Active, no longer recruiting
Phase of Trial: Phase I
Latest Information Update: 13 Oct 2017
At a glance
- Drugs Tc 99m ethylenedicysteine deoxyglucose (Primary)
- Indications Head and neck cancer
- Focus Diagnostic use
- 09 Oct 2017 Planned End Date changed from 1 Sep 2017 to 1 Aug 2018.
- 09 Oct 2017 Planned primary completion date changed from 1 Sep 2017 to 1 Aug 2018.
- 12 Apr 2017 Planned End Date changed from 1 Mar 2017 to 1 Sep 2017.